• About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • IRS Form 8937
    • Stock Performance
      • Historical Stock Lookup
      • Analyst Coverage
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Studies Now Enrolling
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact

Events & Presentations

Latest Presentation
View the latest presentation

View the latest presentation
(2.8 MB)
 
Curis First Quarter 2026 Business Update
 Tuesday, May 12, 2026
 4:30pm - 5:30pm EDT
 Listen to the Webcast
© Curis, Inc. 2026 - All Rights Reserved
  • Terms of Use
  • Privacy Policy
  • About
    • Company Overview
    • Management
    • Board of Directors
    • Advisory Board
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • Current Studies
      • Sponsored
        • TakeAim Lymphoma
        • TakeAim Leukemia
    • Understanding Primary CNS Lymphoma
    • Compassionate Use Policy
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • Fimepinostat
    • CA-170
    • CA-327
  • Scientific Resources
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact